Neogen NEOG
NASDAQ NEOG
$11.95 +0.12 (+1.01%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neogen (NEOG) Cash from Investing Activities (2010 - 2026)

Neogen (NEOG) posted quarterly Cash from Investing Activities of -$4.0 million for Q2 2026, up 74.84% year-over-year from -$2.3 million in Q2 2025, and up 65.39% quarter-over-quarter from -$11.6 million in Q1 2026.

Neogen (NEOG) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Neogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$4.0 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities rose 74.84% year-over-year to -$4.0 million; the TTM figure through May 2026 stood at $70.5 million (up 171.07% YoY), while the FY2026 annual figure was $70.5 million, up 171.07% from the prior year.
  • Cash from Investing Activities for Q2 2026 stood at -$4.0 million, up from -$11.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $97.7 million in Q3 2025, with the low at -$33.7 million in Q3 2024.
  • The 5-year median for Cash from Investing Activities is -$11.6 million (2025), against an average of $6.1 million.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities jumped 421.32% in 2022, then tumbled 354.71% in 2024.
  • Neogen's Cash from Investing Activities stood at $93.0 million in 2022, then plunged by 87.6% to $11.5 million in 2023, then slumped by 248.73% to -$17.2 million in 2024, then jumped by 31.99% to -$11.7 million in 2025, then soared by 65.72% to -$4.0 million in 2026.
  • Business Quant data shows NEOG's Cash from Investing Activities at -$4.0 million in Q2 2026, -$11.6 million in Q1 2026, and -$11.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -673.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -639.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -193.20 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -22.08 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -108.50 Mn
10 Neogen 2.61 Bn 2.42 Bn 107.80 Mn -4.00 Mn

Historic Data

Download Data
DateValue
May 31, 2026 -4.00 Mn
May 31, 2026 -4.00 Mn
Feb 28, 2026 -11.56 Mn
Feb 28, 2026 -11.56 Mn
Nov 30, 2025 -11.67 Mn
Nov 30, 2025 -11.67 Mn
Aug 31, 2025 97.73 Mn
Aug 31, 2025 97.73 Mn
May 31, 2025 -15.90 Mn
May 31, 2025 -15.90 Mn
Feb 28, 2025 -32.48 Mn
Feb 28, 2025 -32.48 Mn
Nov 30, 2024 -17.16 Mn
Nov 30, 2024 -17.16 Mn
Aug 31, 2024 -33.66 Mn
Aug 31, 2024 -33.66 Mn
May 31, 2024 -17.52 Mn
May 31, 2024 -17.52 Mn
Feb 29, 2024 -14.64 Mn
Feb 29, 2024 -14.64 Mn